Srn Advisors, LLC Danaher Corp Transaction History

Srn Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2024	SELL	$241.42 - $282.29 $738,503 - $863,525	-3,059 Closed	0 $0
Q3 2022 Jun 14, 2024	SELL	$247.06 - $1507.4 $145,765 - $889,366	-590 Reduced 16.17%	3,059 $790 Million
Q2 2022 Jun 14, 2024	SELL	$237.11 - $299.66 $144,637 - $182,792	-610 Reduced 14.32%	3,649 $925 Million
Q1 2022 Jun 14, 2024	BUY	$257.27 - $315.76 $16,979 - $20,840	66 Added 1.57%	4,259 $1.25 Billion
Q4 2021 Jun 14, 2024	BUY	$292.08 - $329.01 $1.22 Million - $1.38 Million	4,193 New	4,193 $1.38 Billion

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Srn Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Srn Advisors, LLC with notifications on news.